What's new in neuromyelitis optica? A short review for the clinical neurologist.

about

Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.

P2860

Q47104784-9EF4B8F8-CF6F-4303-8E66-C71E3132D46D

P2860

What's new in neuromyelitis optica? A short review for the clinical neurologist.

Item

http://www.wikidata.org/entity/Q39176987

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

What's new in neuromyelitis optica? A short review for the clinical neurologist.

@en

What's new in neuromyelitis optica? A short review for the clinical neurologist.

@nl

type

Item

label

What's new in neuromyelitis optica? A short review for the clinical neurologist.

@en

What's new in neuromyelitis optica? A short review for the clinical neurologist.

@nl

prefLabel

What's new in neuromyelitis optica? A short review for the clinical neurologist.

@en

What's new in neuromyelitis optica? A short review for the clinical neurologist.

@nl

P1476

What's new in neuromyelitis optica? A short review for the clinical neurologist.

@en

P2093

Anu Jacob

http://www.w3.org/2001/XMLSchema#string

Daniel Whittam

http://www.w3.org/2001/XMLSchema#string

Geoff Keir

http://www.w3.org/2001/XMLSchema#string

Maneesh Bhojak

http://www.w3.org/2001/XMLSchema#string

Martin Wilson

http://www.w3.org/2001/XMLSchema#string

Shahd Hamid

http://www.w3.org/2001/XMLSchema#string

P2860

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis

Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

P2888

s00415-017-8445-8

P31

scholarly article

P356

10.1007/S00415-017-8445-8

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28289845

http://www.w3.org/2001/XMLSchema#string

What's new in neuromyelitis optica? A short review for the clinical neurologist.

about

P2860

P2860

What's new in neuromyelitis optica? A short review for the clinical neurologist.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698